| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092512 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents |
| 05/13/2004 | US20040092510 Novel 2, 3 - benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 05/13/2004 | US20040092509 Controlling dosage times |
| 05/13/2004 | US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | US20040092500 Methods and therapeutic combinations for the treatment of demyelination |
| 05/13/2004 | US20040092499 Methods and therapeutic combinations for the treatment of autoimmune disorders |
| 05/13/2004 | US20040092486 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 05/13/2004 | US20040092481 Eating disorders; irritable bowel disorders; headaches; obsessive compulsive disorders |
| 05/13/2004 | US20040092473 Method for nucleic acid transfection of cells |
| 05/13/2004 | US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040092444 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 05/13/2004 | US20040092438 Antiischemic agents; brain disorders; ganglioside antagonist |
| 05/13/2004 | US20040092429 Cardiovascular disorders; antiarrhythmia agents; controlling phosphorylation of cells, tissues |
| 05/13/2004 | US20040092427 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 05/13/2004 | US20040091960 Novel physiologically active peptides and use thereof |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/13/2004 | US20040091942 Measuring concentration of phospho-tau protein in body/brain fluids for detecting alzheimer's, nervous system and brain disorders |
| 05/13/2004 | US20040091532 One-a-day, oral administration of a methylphenidate drug, e,g, Ritalin, the dosage of which form provides an immediate dose upon ingestion followed by release of more dose(s) later; particles uncoated/coated with ammonio methacrylate |
| 05/13/2004 | US20040091529 Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| 05/13/2004 | US20040091525 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitor component |
| 05/13/2004 | US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models |
| 05/13/2004 | US20040091464 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/13/2004 | US20040091458 Method for reducing pain using oncolytic viruses |
| 05/13/2004 | DE10250080A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | DE10240818A1 Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate Substituted 2-pyrrolidin-2-yl- [1,3,4] oxadiazol-derivatives |
| 05/13/2004 | CA2504205A1 Angiotensin-converting enzyme containing medecine |
| 05/13/2004 | CA2504201A1 Mucuna pruriens and extracts thereof for the treatment of neurological diseases |
| 05/13/2004 | CA2503624A1 Use of a nitric oxide donor to prevent desensitization of g-protein coupled receptors |
| 05/13/2004 | CA2502704A1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/13/2004 | CA2500850A1 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 05/13/2004 | CA2499502A1 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone |
| 05/12/2004 | EP1418293A1 System for the construction of water retaining walls, such as swimming pool walls, with prefabricated panels |
| 05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
| 05/12/2004 | EP1417963A1 Highly purified EPA and derivatives for psychiatric and neurological disorders |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |
| 05/12/2004 | EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 05/12/2004 | EP1417211A2 Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses |
| 05/12/2004 | EP1417206A1 NOVEL 2 i H /i -PYRIDAZINE-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND A PROCESS FOR THE PREPARATION OF THE ACTIVE INGREDIENT |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417203A1 S-6-hydroxy-buspirone |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417189A1 Acylaminothiazole derivatives, their preparation and therapeutic use |
| 05/12/2004 | EP1417188A1 Novel 2,4-diaminothiazole derivatives |
| 05/12/2004 | EP1417187A1 Aryl substituted thiazolidinones and the use thereof |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417174A2 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2004 | EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416966A2 Methods for treating joint inflammation, pain, and loss of mobility |
| 05/12/2004 | EP1416962A2 Method of improving cognitive function |
| 05/12/2004 | EP1416956A2 Autologous t-cell vaccines materials and method |
| 05/12/2004 | EP1416951A1 Melanin-concentrating hormone antagonists |
| 05/12/2004 | EP1416950A1 Artichoke leaf extracts |
| 05/12/2004 | EP1416948A1 Compositions for removal of toxins |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416937A1 Prophylactic and therapeutic use of hydroxysteroids |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416930A1 Pramipexole for the treatment of adhd |
| 05/12/2004 | EP1416921A2 Once-a-day oxycodone formulations |
| 05/12/2004 | EP1416915A1 Enhanced pharmacokinetic profile of hydrophobic substances |
| 05/12/2004 | EP1416842A2 Pharmaceutical combinations of oxycodone and naloxone |
| 05/12/2004 | EP1416795A1 Compositions and methods for treatment of mitochondrial diseases |
| 05/12/2004 | EP1345936B1 Method for producing the anticholinergic agent tiotropium bromide |
| 05/12/2004 | EP1250336B1 Piperidine derivatives and their use as serotonin receptor antagonists |
| 05/12/2004 | EP1244638B1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 05/12/2004 | EP1218352B1 Benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1100497B1 Heterocyclyl sulphonamide derivatives |
| 05/12/2004 | EP1062212B1 Heterocyclyl anthracyclinone derivatives |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP0960105B1 Benzofurazan compounds that enhance ampa receptor activity |
| 05/12/2004 | EP0946510B1 Novel compounds with analgesic effect |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0792156B1 Medicaments for the prevention or treatment of vascular hemorrhaging |
| 05/12/2004 | CN1496404A Materials and methods relating to protein aggregation in neurodegenerative disease |
| 05/12/2004 | CN1496366A Triazolopyridines as anti-inflammatory agents |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496361A 苯基衍生物3 Phenyl derivative 3 |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496352A Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and use of same as analgesics |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496350A Improved process for preparing pure ondansetron hydrochloride dihydrate |
| 05/12/2004 | CN1496349A (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane, compositions and uses thereof |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |